Roadmap for Transforming Obesity Disease Management
Roadmap for Transforming Obesity Disease Management
July 25, 2025
Last month, the Center for Biomedical System Design (CBSD) program at Tufts Medical Center's Institute for Clinical Research and Health Policy Studies published a comprehensive roadmap for transforming obesity disease management in the United States.
Guest Letter: Metabolic Health Matters: Addressing Obesity and Advancing Solutions in Fatty Liver Disease
Guest Letter: Metabolic Health Matters: Addressing Obesity and Advancing Solutions in Fatty Liver Disease
June 28, 2025
On the second Thursday in June, Global Fatty Liver Day brings overdue attention to one of the most widespread yet overlooked public health threats of our time: fatty liver disease.
Employer Insurance Coverage of Obesity Treatment
Employer Insurance Coverage of Obesity Treatment
May 29, 2025
Limitations in access and coverage of obesity medications has paralleled the advances in the usage of GLP-1s.
Roadmap for Transforming Obesity Disease Management
Last month, the Center for Biomedical System Design (CBSD) program at Tufts Medical Center's Institute for Clinical Research and Health Policy Studies published a comprehensive roadmap for transforming obesity disease management in the United States.
On the second Thursday in June, Global Fatty Liver Day brings overdue attention to one of the most widespread yet overlooked public health threats of our time: fatty liver disease.
Employer Insurance Coverage of Obesity Treatment
Limitations in access and coverage of obesity medications has paralleled the advances in the usage of GLP-1s.
Guest Letter: Concerns About Compounded GLP-1 Medications
OAC has long advised our members against using compounded GLP-1’s. The main reason is FDA’s own words about compounding.
FDA's New Draft Guidance for Obesity Medications
This past January the FDA published a draft guidance entitled “Obesity and Overweight: Developing Drugs and Biological Products for Weight Reduction.”
OCW's theme this year is “Commit to Care,” to encourage everyone to advocate for accessible, affordable, respectful, and compassionate obesity care.
Lancet Commission Report on Clinical Obesity
On January 14th, the Lancet Diabetes and Endocrinology Global Commission released a report on the definition and diagnostic criteria of clinical obesity.
CMS Proposes Rule to Cover Obesity Medications
In late November, the Centers for Medicare and Medicaid Services (CMS) officially proposed a rule to cover obesity medications in Medicare and Medicaid.
The Impact of Rising Rates of Obesity and Diabetes
November was National Diabetes Month, which provides a perfect opportunity to remind us to look again at the associated diagnoses of diabetes for individuals with obesity.
Due to the shortages of obesity medications, some patients are turning to pharmacies that produce compounded versions of these medications.
Subscribe below to receive STOP's monthly email packed with insights from experts in obesity prevention and treatment, details on upcoming events, and exciting news from our member organizations!